Co-occurrence of Frailty, Possible Sarcopenia, and Malnutrition in Community-Dwelling Older Outpatients: A Multicentre Observational Study

Article information

Ann Geriatr Med Res. 2025;29(1):91-101
Publication date (electronic) : 2024 December 18
doi : https://doi.org/10.4235/agmr.24.0144
1Division of Geriatric Medicine, Department of Internal Medicine, Cipto Mangunkusumo Hospital – Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
10School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, North Jakarta, Indonesia
11Department of Internal Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia
12Department of Internal Medicine, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia
2Department of Internal Medicine, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia
3Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
4Department of Internal Medicine, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
5Department of Internal Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
6Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
7Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
8Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
9Department of Internal Medicine, Faculty of Medicine, Universitas Andalas, Padang, Indonesia
Corresponding Author: Siti Setiati, MD, MEpid, PhD Division of Geriatric Medicine, Department of Internal Medicine, Cipto Mangunkusumo Hospital – Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia E-mail: s_setiati@yahoo.com
Received 2024 August 28; Revised 2024 November 25; Accepted 2024 December 1.

Abstract

Background

The co-occurrence of frailty, sarcopenia, and malnutrition was well studied in inpatient and nursing home settings, which was associated with higher risk of all-cause mortality. Multicentre data in community-dwelling outpatient setting were lacking. We aimed to find the prevalence of frailty, possible sarcopenia and malnutrition, their overlap and the associated factors in community-dwelling older outpatients.

Methods

We collected data from community-dwelling outpatients aged ≥60 years in Indonesian geriatric care centres to conduct this cross-sectional study with bivariate and multivariable analyses. Frailty, possible sarcopenia, and malnutrition diagnoses were based on FRAIL scale, Asian Working Group for Sarcopenia 2019 consensus, and Mini Nutritional Assessment Short Form, respectively.

Results

The prevalence of frailty, possible sarcopenia, and malnutrition in community-dwelling older outpatients were 13.6%, 45.5%, and 5.3%, respectively. The prevalence of co-occurrence of frailty, possible sarcopenia and malnutrition was 3.3%. It was associated with transient ischemic attack (TIA) and cerebrovascular accident (odds ratio [OR]=5.53, 95% confidence interval [CI] 1.48–20.61), cognitive impairment (OR=3.70, 95% CI 1.21–11.31), and dependent functional capacity (OR=11.62, 95% CI 3.38–39.99). Overlap of three evaluated syndromes was found in 24.1%, 7.2%, and 61.3% of subjects with frailty, possible sarcopenia, and malnutrition, respectively. It was characterized by a substantial proportion of female sex, older adults with low educational attainment, diabetes mellitus, hypertension, cognitive impairment, multimorbidity, and dependent functional status.

Conclusion

Approximately 1 in 30 community-dwelling older outpatients had overlapping frailty, possible sarcopenia, and malnutrition. The condition is associated with TIA and cerebrovascular accident, cognitive impairment, and dependent functional capacity. Standardized screening in community-dwelling older population is necessary.

INTRODUCTION

Frailty, sarcopenia and malnutrition share similar etiological factors, including inflammation, lower food intake, higher energy requirements, lower physical activity, and hormonal alteration.1,2) The loss of fat-free mass in frailty and sarcopenia was crucial, whereas in malnutrition the reduction of both fat and fat-free mass occurred.3) These three syndromes may coexist in older adults due to the similarities in definition and etiology. Concurrent occurrence of three syndromes might affect outcome and indicate the need for proper treatment. UK Biobank data analysis suggested that older adults with frailty and two other conditions or more (sarcopenia, malnutrition, and/or cachexia) had five times higher risk of all-cause mortality compared to older adults without those geriatric syndromes.4) Not only does the co-occurrence affect survival,4) it also affects the cost and the use of healthcare resources.5)

The overlap of frailty, sarcopenia, and malnutrition has been well studied in inpatient cohorts,6) and nursing home population.7) In community-dwelling older adults, several studies reported significant overlaps between frailty and malnutrition,8) and between sarcopenia and frailty.9) A single-centre study among older outpatients in a geriatric clinic in Turkey reported that 53% frail older adults were sarcopenic, and 27.1% of older adults had more than four syndromes, which may include frailty, malnutrition, and sarcopenia.10) As life expectancy increases in many parts of the world, frailty, sarcopenia and malnutrition may become a growing economic burden.11) To date, study about the overlap of three syndromes in community-dwelling outpatient setting in Indonesia is lacking.

In this multicentre study, we aimed to find the prevalence of frailty, possible sarcopenia and malnutrition, their overlap and the associated factors in multi-ethnic community-dwelling older outpatients. The result of this study would be the first of its kind in the region and serves as information for physicians taking care of older adults.

MATERIALS AND METHODS

Study Design and Subjects

This cross-sectional study was conducted in several geriatric care centres in different islands of Indonesia, which were Cipto Mangunkusumo National General Hospital in Central Jakarta, Atma Jaya Private Hospital in North Jakarta, Dr Mohammad Hoesin General Hospital in Palembang, Siti Khadijah Islamic Hospital in Palembang, Haji Adam Malik General Hospital in Medan, Dr Wahidin Sudirohusodo General Hospital in Makassar, Dr Soetomo General Hospital in Surabaya, Dr Hasan Sadikin General Hospital in Bandung, Dr Saiful Anwar General Hospital in Malang, Dr Mohammad Djamil General Hospital in Padang, Dr Kariadi General Hospital in Semarang, and Dr Moewardi General Hospital in Surakarta. We obtained the data from multi-ethnic Indonesian adults aged 60 years and older. The interviewers were trained physicians caring for older adults. Data collection process was done from April to October 2022. The subjects provided their written informed consent to participate in this study. We excluded patients with acute illness(es) and/or incomplete data, as we believed that acute illness(es) may affect the examination results related to malnutrition, sarcopenia, and/or frailty. Ethical approval was obtained from the Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, with registration number KET-369/UN2.F1/ETIK/PPM.00.02/2020.

Frailty Definition

Frailty state was assessed using the FRAIL scale. One point was given if the older adult reported each diagnostic tool criterion. The criteria consist of fatigue, resistance (defined as the ability to climb one flight of stairs), ambulation (walk a block), number of co-morbid illnesses <5, and weight loss of more than 5% in the previous year. If the total score was 3 or higher, the patient was categorized as frail. If the total score was 0, the patient was categorized as robust, whereas the total score of 1 or 2 indicates pre-frailty.12)

Possible Sarcopenia Definition

Possible sarcopenia in this study was based on possible sarcopenia diagnostic criteria from Asian Working Group for Sarcopenia (AWGS) 2019 consensus.13) Diagnosis began with case finding with the measurement of calf circumference (<34 cm for male and <33 cm for female) or completing SARC-F questionnaire. The latter consists of five components, namely strength, assistance in walking, rise from a chair, climb stairs, and fall. The SARC-F has been adapted and validated in Indonesian population,14) and its performance was highly sensitive and specific for detecting sarcopenia based on the criteria from European Working Group for Sarcopenia in Older People (EWGSOP) and from AWGS in 2019.14)

Following case finding, the diagnosis of possible sarcopenia requires the assessment of muscle strength or physical performance. The former was assessed by handgrip strength, whereas the latter was assessed by five times sit to stand (FTSTS) test. Handgrip strength was considered low if the result was <28 kg for male and <18 kg for female. Physical performance was considered abnormal if the result of FTSTS test was 12 seconds or higher.13) We obtained 3 readings of handgrip strength for each person using JAMAR hand dynamometer (Sammons Preston Rolyan, Bolingbrook, IL, USA). All measurements are standardised across different clinics.

Malnutrition Definition

Malnutrition in this study was defined as the Mini Nutritional Assessment–Short Form (MNA-SF) score <11. The assessment tool was selected for its simplicity and fair sensitivity and specificity to diagnose malnutrition based on the Global Leadership Initiative on Malnutrition (GLIM) criteria. MNA-SF consists of objective features of malnutrition, such as body mass loss, decreased food intake, and the presence of an acute illness or stress during the preceding three months. Additionally, it also assesses the subject’s body mass index, presence of any neuropsychological disorders (depression or dementia), mobility and limitations.15)

Covariates

We collected details from each individuals as follows. Sex was categorized as male or female. Age was categorized as 60–69 years or 70 years and older. Age cut-off point was based on previous report of community-dwelling older adults in Indonesia16) and Malaysia.17) Ethnic groups were categorised into Sundanese, Batak, Betawi, Javanese, Malay, Minang, Chinese and others. In this study Malay ethnic group included people native to the regions on the east coast of Sumatra island, such as Deli Malay and Palembang Malay. Smoking history was documented as never-smoker, former or current smoker. Information regarding past medical history was collected through history taking and from medical records. Diagnoses were made by physicians. We took into account past medical history such as diabetes mellitus, chronic kidney disease, cardiovascular disease, transient ischemic attack (TIA) and cerebrovascular accident, dementia, hypertension, osteoarthritis, dyslipidaemia, falls and recurrent falls. Falls were defined as history of one fall or more during the previous 12 months, whereas recurrent falls were defined as history of two falls or more during the preceding 12-month period.18) In comprehensive geriatric assessment (CGA), we collected data regarding cognitive function, depression and functional status. We used 10-point abbreviated mental test (AMT or AMT-10) and classified cognitive impairment with cut-off point of 6. AMT was known for its reasonable test performance.19) Functional status was categorized as independent or dependent, depending on Barthel Index of activity of daily living (ADL) questionnaire. Score of below 20 in the ADL questionnaire indicates dependent functional status.16) Depression variable was determined by the result of five items of Geriatric Depression Scale (GDS-5) at cut-off point 2.20) Multimorbidity was defined as the co-occurrence of more than one chronic conditions.21,22) We defined polypharmacy as the administration of five or more medications daily.23)

Statistical Analyses

We analyzed the data with SPSS version 21 (IBM, Armonk, NY, USA). We provided descriptive data of frailty, sarcopenia, malnutrition, and the overlap of the evaluated geriatric syndromes. We used chi-square test to perform the bivariate analysis, followed by multivariable analysis to assess the association between the overlap of syndromes and the covariates. Variables with p-value <0.25 in bivariate analysis were included in multivariable analysis using multiple logistic regression method.24) The alpha level for the study was set at 0.05.

RESULTS

Among 580 older adults in this study, 54.1% were female and 51.7% were aged between 60 and 69 years (Table 1). A larger proportion had high educational attainment (68.3%) and Javanese older adults contributed to 27.2% of study population. A larger proportion of older adults never smoke, did not have history of falls, recurrent falls, diabetes mellitus, chronic kidney disease, cardiovascular disease, TIA and cerebrovascular accident, dementia, osteoarthritis, and dyslipidaemia.

Characteristics of participants (n=580)

The prevalence of overlap of three syndromes were 3.3%, whereas the prevalence of frailty, possible sarcopenia, and malnutrition in this study cohort were 13.6%, 45.5%, and 5.3%, respectively. Frailty assessment results showed that 55.0% and 31.4% of older adults were pre-frail and robust, respectively. The overlap of three syndromes was found in 24.1%, 7.2%, and 61.3% of older adults with frailty, possible sarcopenia, and malnutrition, respectively (Fig. 1). Older adults with three overlapping syndromes were characterized by large proportion of female sex (78.9%), older adults with low educational attainment (52.6%), diabetes mellitus (57.9%), hypertension (57.9%), cognitive impairment (57.9%), multimorbidity (78.9%), and dependent functional status (79.9%). 36.8% of this group of outpatients were of Chinese descent. There is higher proportion of older adults without history of cardiovascular disease (52.9%), osteoarthritis (78.9%), dyslipidaemia (68.4%), polypharmacy (84.2%), and depression (73.7%).

Fig. 1.

Frailty, SARC-F-based sarcopenia, and malnutrition diagnoses among community-dwelling older outpatients in Indonesia (n=580). SARC-F contains five items: strength, assistance in walking, rising from a chair, climbing stairs, and falls.

We found similar findings regarding factors with higher prevalence if we took into account frailty, possible sarcopenia, and malnutrition separately, except in certain cases as follows. Although more older adults with low educational attainment had overlap of three syndromes, there were larger proportion of older adults with high educational attainment in frailty, possible sarcopenia, and malnutrition group separately. Javanese older adults made up 25.3% and 29.2% of older adults with frailty and possible sarcopenia, respectively, whereas Chinese older adults were the most prevalent ethnic group in older adults with malnutrition (32.3%). There was history of cardiovascular disease in 51.9% and 54.8% older adults with frailty and malnutrition, respectively. Cognitive impairment was found in 69.6% and 84.1% of older adults with frailty and possible sarcopenia, respectively. A higher proportion of older adults with possible sarcopenia were functionally independent (58.3%).

Bivariate analysis results showed a number of factors with p-value <0.25, which are female sex, low educational attainment, former or current smoker, falls, recurrent falls, diabetes mellitus, TIA and cerebrovascular accident, dementia, polypharmacy, cognitive impairment, independent functional status and depression (Table 2). The variables were subsequently included in multivariable analysis. Multivariable analysis results showed statistically significant relationship between the overlap of frailty, possible sarcopenia and malnutrition, and three evaluated factors, namely TIA and cerebrovascular accident (odds ratio [OR]=5.53, 95% confidence interval [CI] 1.48–20.61), cognitive impairment (OR=3.70, 95% CI 1.21–11.31), and dependent functional capacity (OR=11.62, 95% CI 3.38–39.99).

The odds ratio for the association between each factor and the overlap of frailty, possible sarcopenia, and malnutrition

DISCUSSION

In this study, we found that the prevalence of overlap of frailty, possible sarcopenia, and malnutrition was 3.3%. The condition is associated with TIA and cerebrovascular accident, cognitive impairment, and dependent functional capacity.

Prevalence of Frailty, Possible Sarcopenia and Malnutrition Alone

The prevalence of FRAIL scale-based frailty in this multicentre study population was 13.6%. Previous multicentre studies also suggested similar epidemiological data in community-dwelling older adults in the region.16,25) Frailty is linked to functional dependence, depression, history of fall, polypharmacy, malnutrition,16) and possible sarcopenia. Even without sarcopenia diagnosis, frailty itself is a strong predictor of mortality,26) and is associated with hospitalization and low quality of life.27) Frailty assessment results in our study showed that 55.0% and 31.4% of older adults were pre-frail and robust, respectively.

The prevalence of possible sarcopenia in this study was 45.5%. The finding was in line with the reported prevalence of sarcopenia in Asia using AWGS definition, which ranged from 2.5 to 45.7%.28,29) Asian population may have higher prevalence of sarcopenia than non-Asian community. In this study, we decided to use possible sarcopenia criteria due to its excellent diagnostic accuracy. Previous study involving Japanese older adults suggested that for male population the sensitivity and specificity to predict sarcopenia were 89.3% and 99.0%, respectively. In addition, the sensitivity and specificity in female population were 92.1% and 87.0%, respectively.30) The possible sarcopenia criteria included SARC-F questionnaire in the case finding stage, which was a validated tool in Indonesian population, with high sensitivity and specificity for detecting sarcopenia based on the criteria from AWGS and EWGSOP.14) In order to address the problem of obstacles to disseminating the diagnosis and treatment of sarcopenia based on criteria utilizing dual-energy X-ray absorptiometry (DXA) or bioelectrical impedance analysis (BIA) method, the AWGS 2019 has added possible sarcopenia criteria with simple assessments. This potentially promotes early detection and intervention of sarcopenia, especially in resource-limited settings.

The prevalence of malnutrition in this study was 5.3%. This finding was supported by the previous systematic review of observational studies suggesting that the prevalence of malnutrition on the basis of MNA result in Indonesia ranged from 2.1 to 14.6%.31)

Therefore, approximately 1 out of 10 had frailty, 1 out of 2 had possible sarcopenia, and 1 out of 20 had malnutrition. Thus, primary care and specialized outpatient clinics should be involved in the detection of these prevalent geriatric syndromes, as the evaluated syndromes may be reversible if addressed properly.32) If patients were proven not to have these preventable geriatric syndromes, prevention should be included in the interdisciplinary care for the older adult.

Overlap of Frailty, Possible Sarcopenia, and Malnutrition

The prevalence of overlap of frailty, possible sarcopenia and malnutrition in our outpatient study was 3.3%. It was lower than the result of similar study in nursing home setting (14.5%)7) and in medical inpatient setting (approximately 8%).6)

As the coexistence of three evaluated geriatric syndromes have implications for outcome and proper treatment, appropriate screening may be required in older population. This may suggest the need for comprehensive geriatric assessment (CGA). When applied to community-dwelling older adults, outpatient CGA may delay the progression frailty and contribute to the improvement of frail older adults with multimorbidity.33) CGA remained the gold standard for caring for frail older adults with frailty, as stated in the best practice guidelines on the management of frailty by several medical societies.

The detection of disease(s) and/or geriatric syndrome(s) through CGA can be followed by appropriate management of the problems. The substantial overlap of three evaluated syndromes may also indicate that older outpatients are likely to benefit from nutritional support with a protein-enriched diet as appropriate.34) A systematic review of observational studies in the region also identified a high prevalence of protein inadequacy among Indonesian community-dwelling older adults.31)

Interestingly, the three syndromes were found in parallel in 24.3%, 7.2%, and 61.1% older adults with frailty, possible sarcopenia, and malnutrition, respectively. This indicates that a majority of malnourished older adults also had frailty and possible sarcopenia. Recently, sarcopenia was detected to be the mediating factor that could explain the indirect relationship between malnutrition and frailty.35) However, malnutrition may be directly linked to frailty as well. Previous study showed that malnutrition-sarcopenia syndrome was four times more likely to die than other nonsarcopenic adults with normal nutritional status.36) Sarcopenia and malnutrition may be present in parallel via a combination of several factors, including inflammation, decreased body weight, decreased food intake, disease burden, as well as altered endocrine and immune systems. Even without malnutrition, a recent systematic review and meta-analysis suggested that adults with sarcopenia had two times higher risk of mortality than adults without sarcopenia, irrespective of sarcopenia definition and population.37)

In this study, older adults with three overlapping syndromes were characterized by a substantial proportion of female sex, older adults with low educational attainment, diabetes mellitus, hypertension, cognitive impairment, multimorbidity, and dependent functional status. However, not all of the covariates were associated with the overlap of frailty, possible sarcopenia and malnutrition.

Relationship with TIA and Cerebrovascular Accident

Our data suggested that overlap of frailty, possible sarcopenia, and malnutrition was associated with TIA and cerebrovascular accident (OR=4.65, 95% CI 1.17–18.47). A recent systematic review and meta-analysis of 18 studies reported the prevalence of frailty in individuals with stroke as 22%.38) Our study, also suggested similar finding, in which 10 out of 41 patients with diagnosis of TIA and cerebrovascular accident were frail (24.4%). In patients with stroke, the prevalence of frailty to be two-fold compared to those without stroke. Further research is required to prove potential bi-directional relationship between stroke and frailty, that might lead to a self-propagating cycle suggested by Evans and colleagues.39) In the cycle, frail older adults may have lower response to treatment, leading to poorer stroke recovery and increased number of stroke events. Following TIA and cerebrovascular accident, individuals with greater frailty may have worse outcomes, including greater length of stay, higher readmission, higher 90-day mortality, and worse health-related quality of life. In addition, frailty is a major factor influencing cessation of therapy in patients with atrial fibrillation who are on anticoagulant regimen.40) This may lead to worsening of stroke risk factors and higher severity of stroke.

The statistically significant relationship between TIA and cerebrovascular accident, and the overlap of frailty, possible sarcopenia and malnutrition can also be explained by the potential negative impacts of cerebrovascular accident on nutrient intake. Numerous studies have consistently demonstrated that patients who had stroke could not achieve the recommended nutritional intake.41) Poor nutritional status is associated with worse stroke outcomes. The combination of poor nutritional status, immobilization and inactivity after cerebrovascular accident could lead to possible sarcopenia and negatively impact the recovery after stroke.42) The presence of possible sarcopenia prior to a stroke may also be more common than suspected and lead to worse functional recovery,42) which may indicate suspected bidirectional relationship between possible sarcopenia and cerebrovascular accident.

Relationship with Cognitive Impairment

Cognitive impairment based on AMT-10 in our study is linked to the overlap of frailty, possible sarcopenia, and malnutrition (OR=3.55, 95% CI 1.16–10.89). A systematic review and meta-analysis of six observational studies concluded that baseline frailty was associated with higher risk of cognitive disorders (including dementia and mild cognitive impairment [MCI]).43)

Experts have also suggested the role of nutritional status as the mediating variable in the association between cognitive decline and sarcopenia, although the relationship between the two are bidirectional and complex. Firstly, pro-inflammatory factors such as interleukin-6 (IL-6) is higher in patients with cognitive impairment44) and sarcopenia.45) Secondly, nitrosative and oxidative stress products accumulate during ageing process and potentially cause cognitive impairment.46) Thirdly, older adults with cognitive decline often forget to eat, become less able to prepare and access food, all of which potentially impair food intake per oral and subsequently result in malnutrition. Not only do older adults with cognitive impairment demonstrate lower dietary intake but also reduced physical activity that potentially triggers excessive muscle loss and accelerate sarcopenia. On the other hand, malnutrition may also promote cognitive decline and cause subsequent increase in the risk of sarcopenia and functional dependence.47)

Relationship with Dependent Functional Capacity

Dependent functional capacity is also associated with the overlap of three syndromes in our study (OR=12.16, 95% CI 3.50–42.29). The combination of frailty and possible sarcopenia in an older adult may lead to physical function impairment characterized by weak muscle strength, poor balance, and slow walking speed. We hypothesized that the relationship may be bidirectional, as sarcopenia leads to impaired ability to perform ADL, and inactivity may also accelerate sarcopenia.48) Taken all in all, we provided the illustration of findings related to the relationship between statistically significant covariates and the overlap of three evaluated syndromes, including the hypothesized bi-directional link (Fig. 2).

Fig. 2.

The postulated relationship between the overlap of frailty, possible sarcopenia and malnutrition, and TIA and cerebrovascular accident, cognitive impairment, and dependent functional capacity. TIA, transient ischemic attack.

Future Direction and Limitations

Multinational experts previously suggested standardized screening for these conditions at hospital admission.34) In addition, we suggest standardized screening procedure in older population at the community level to detect frailty, possible sarcopenia and malnutrition alone or in combination. This may help physicians detect geriatric syndromes and acts as secondary preventive strategy to stop age-associated disability. Early intervention following the detection of geriatric syndromes may decrease hospitalization and mortality.49)

One feasible strategy is by using Rapid Geriatric Assessment (RGA) tool established at St. Louis University, which only takes less than 5 minutes to screen the aforementioned geriatric problems. The tool has been used in Singapore with promising benefit, both in the form of administered RGA and self-administered RGA.50) Thus, we also suggest validation study for this tool in local older population.

We managed to find out three alarming conditions associated with the occurrence of three geriatric giants. Practice nurses and general practitioners are all well-placed to screen for frailty, sarcopenia, and malnutrition.11) We suggest a holistic referral pathway for individuals who might benefit from geriatric medicine referral. We suggest older adults aged 60 years and older with new, recurrent, or worsening cerebrovascular disease to be referred to consultant geriatrician for thorough assessment of patient’s condition. In addition, we also suggest older adults aged 60 years and older with cognitive impairment to be referred to consultant geriatrician for thorough assessment of patient’s condition. Dependent functional capacity should be an alarm, too.

To the best of our knowledge, this multicentre observational study was the first to evaluate the overlap of frailty, possible sarcopenia and malnutrition in Indonesian archipelago. By involving various centres on different islands, our multicentre study may represent the real population better. Multivariable analysis in this multicentre study helped adjust study variables appropriately. However, we acknowledge limitations of the study that need to be considered. First, causal links could not be assessed by this study design. Future longitudinal study in this field may be necessary. Second, we only relied on possible sarcopenia criteria, based on AWGS 2019 consensus on sarcopenia. Possible sarcopenia diagnostic criteria had excellent accuracy in Asian population and could promote early detection and intervention of sarcopenia,30) especially in Indonesia where sophisticated BIA and DXA facilities are not widely available in healthcare centres. Third, the lack of statistical significance in our study could be due to an insufficient sample size, although it was precalculated appropriately.

Conclusion

Among community-dwelling older outpatients, 1 out of 10 had frailty, 1 out of 2 had possible sarcopenia, and 1 out of 20 had malnutrition. Approximately 1 in 30 in the same cohort had overlapping frailty, possible sarcopenia, and malnutrition. The co-occurrence of the aforementioned geriatric problems is characterized by a substantial proportion of female sex, older adults with low educational attainment, diabetes mellitus, hypertension, cognitive impairment, multimorbidity, and dependent functional status. The condition is associated with TIA and cerebrovascular accident, cognitive impairment, and dependent functional capacity. We suggest standardized screening procedure in older population at the community level to detect frailty, possible sarcopenia and malnutrition alone or in combination.

Notes

CONFLICT OF INTEREST

The researchers claim no conflicts of interest.

FUNDING

None.

AUTHOR CONTRIBUTIONS

Conceptualisation, SSe, KH, IF, ND, RI, MKA, IGPSA, SSu, AS, DAA, LD, NW, NR, RM, R, YMM, FB, NKS; Methodology, SSe, KH, IF, ND, RI, MKA, IGPSA, SSu, AS, DAA, LD, NW, NR, RM, R, YMM, FB, NKS; Data acquisition, IF, RI, MKA, IGPSA, SSu, AS, DAA, LD, NW, NR, RM, R, YMM, FB, NKS; Data analysis, SSe, IF, MKA; Writing–original draft, SSe, KH, IF, ND, RI, MKA, IGPSA, SSu, AS, DAA, LD, NW, NR, RM, R, YMM, FB, NKS; Writing–review & editing, SSe, KH, IF, ND, RI, MKA, IGPSA, SSu, AS, DAA, LD, NW, NR, RM, R, YMM, FB, NKS.

References

1. Jeejeebhoy KN. Malnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features. Curr Opin Clin Nutr Metab Care 2012;15:213–9. 10.1097/mco.0b013e328352694f. 22450775.
2. Rizka A, Indrarespati A, Dwimartutie N, Muhadi M. Frailty among older adults living in nursing homes in Indonesia: prevalence and associated factors. Ann Geriatr Med Res 2021;25:93–7. 10.4235/agmr.21.0033. 33975423.
3. Gingrich A, Volkert D, Kiesswetter E, Thomanek M, Bach S, Sieber CC, et al. Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients. BMC Geriatr 2019;19:120. 10.1186/s12877-019-1115-1. 31029082.
4. Petermann-Rocha F, Pell JP, Celis-Morales C, Ho FK. Frailty, sarcopenia, cachexia and malnutrition as comorbid conditions and their associations with mortality: a prospective study from UK Biobank. J Public Health (Oxf) 2022;44:e172–80. 10.1093/pubmed/fdaa226. 33423060.
5. Kojima G. Increased healthcare costs associated with frailty among community-dwelling older people: a systematic review and meta-analysis. Arch Gerontol Geriatr 2019;84:103898. 10.1016/j.archger.2019.06.003. 31228673.
6. Rasheedy D, El-Kawaly WH. The cumulative impact of sarcopenia, frailty, malnutrition, and cachexia on other geriatric syndromes in hospitalized elderly. Electron J Gen Med 2021;18em277. 10.29333/ejgm/9695. 40113877.
7. Faxen-Irving G, Luiking Y, Gronstedt H, Franzen E, Seiger A, Vikstrom S, et al. Do malnutrition, sarcopenia and frailty overlap in nursing-home residents? J Frailty Aging 2021;10:17–21. 10.14283/jfa.2020.45. 33331617.
8. Boulos C, Salameh P, Barberger-Gateau P. Malnutrition and frailty in community dwelling older adults living in a rural setting. Clin Nutr 2016;35:138–43. 10.1016/j.clnu.2015.01.008. 25649256.
9. Reijnierse EM, Trappenburg MC, Blauw GJ, Verlaan S, de van der Schueren MA, Meskers CG, et al. Common ground? The concordance of sarcopenia and frailty definitions. J Am Med Dir Assoc 2016;17:371. e7-12. 10.1016/j.jamda.2016.01.013. 26922807.
10. Ates Bulut E, Soysal P, Isik AT. Frequency and coincidence of geriatric syndromes according to age groups: single-center experience in Turkey between 2013 and 2017. Clin Interv Aging 2018;13:1899–905. 10.2147/cia.s180281. 30323576.
11. Roberts S, Collins P, Rattray M. Identifying and managing malnutrition, frailty and sarcopenia in the community: a narrative review. Nutrients 2021;13:2316. 10.3390/nu13072316. 34371823.
12. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012;16:601–8. 10.1007/s12603-012-0084-2. 22836700.
13. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 2020;21:300–7. e2. 10.1016/j.jamda.2019.12.012. 32033882.
14. Dwipa L, Apandi M, Utomo PP, Hasmirani M, Rakhimullah AB, Yulianto FA. Adaptation and validation of the Indonesian version of the FRAIL scale and the SARC-F in older adults. Asian J Gerontol Geriatr 2021;16:40–7. 10.12809/ajgg-2020-436-oa.
15. Kaluzniak-Szymanowska A, Krzyminska-Siemaszko R, Lewandowicz M, Deskur-Smielecka E, Stachnik K, Wieczorowska-Tobis K. Diagnostic performance and accuracy of the MNA-SF against GLIM criteria in community-dwelling older adults from Poland. Nutrients 2021;13:2183. 10.3390/nu13072183. 34202898.
16. Setiati S, Soejono CH, Harimurti K, Dwimartutie N, Aryana IG, Sunarti S, et al. Frailty and its associated risk factors: first phase analysis of multicentre Indonesia longitudinal aging study. Front Med (Lausanne) 2021;8:658580. 10.3389/fmed.2021.658580. 33996862.
17. Sazlina SG, Lee PY, Chan YM, A Hamid MS, Tan NC. The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia. PLoS One 2020;15e0233299. 10.1371/journal.pone.0233299. 32433712.
18. Dai W, Tham YC, Chee ML, Tan NY, Wong KH, Majithia S, et al. Falls and recurrent falls among adults in a multi-ethnic Asian population: the Singapore epidemiology of eye diseases study. Sci Rep 2018;8:7575. 10.1038/s41598-018-25894-8. 29765104.
19. US Preventive Services Task Force. Screening for cognitive impairment in older adults: US preventive services task force recommendation statement. JAMA 2020;323:757–63. 10.1001/jama.2020.0435. 32096858.
20. Branez-Condorena A, Soriano-Moreno DR, Navarro-Flores A, Solis-Chimoy B, Diaz-Barrera ME, Taype-Rondan A. Accuracy of the Geriatric Depression Scale (GDS)-4 and GDS-5 for the screening of depression among older adults: a systematic review and meta-analysis. PLoS One 2021;16e0253899. 10.1371/journal.pone.0253899. 34197527.
21. Almirall J, Fortin M. The coexistence of terms to describe the presence of multiple concurrent diseases. J Comorb 2013;3:4–9. 10.15256/joc.2013.3.22. 29090140.
22. Van Den Akker M, Buntinx F, Knottnerus JA. Comorbidity or multimorbidity: what's in a name? A review of literature. Eur J Gen Pract 1996;2:65–70. 10.3109/13814789609162146.
23. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr 2017;17:230. 10.1186/s12877-017-0621-2. 29017448.
24. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125–37. 10.1093/oxfordjournals.aje.a115101. 2910056.
25. Setiati S, Laksmi PW, Aryana IG, Sunarti S, Widajanti N, Dwipa L, et al. Frailty state among Indonesian elderly: prevalence, associated factors, and frailty state transition. BMC Geriatr 2019;19:182. 10.1186/s12877-019-1198-8. 31269921.
26. Gilardi F, Scarcella P, Proietti MG, Capobianco G, Rocco G, Capanna A, et al. Frailty as a predictor of mortality and hospital services use in older adults: a cluster analysis in a cohort study. Eur J Public Health 2018;28:842–6. 10.1093/eurpub/cky006. 29590362.
27. Limpawattana P, Khammak C, Manjavong M, So-Ngern A. Frailty as a predictor of hospitalization and low quality of life in geriatric patients at an internal medicine outpatient clinic: a cross-sectional study. Geriatrics (Basel) 2022;7:89. 10.3390/geriatrics7050089. 36136798.
28. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95–101. 10.1016/j.jamda.2013.11.025. 24461239.
29. Liu X, Hou L, Xia X, Liu Y, Zuo Z, Zhang Y, et al. Prevalence of sarcopenia in multi ethnics adults and the association with cognitive impairment: findings from West-China health and aging trend study. BMC Geriatr 2020;20:63. 10.1186/s12877-020-1468-5. 32066390.
30. Ueshima J, Maeda K, Shimizu A, Inoue T, Murotani K, Mori N, et al. Diagnostic accuracy of sarcopenia by "possible sarcopenia" premiered by the Asian Working Group for Sarcopenia 2019 definition. Arch Gerontol Geriatr 2021;97:104484. 10.1016/j.archger.2021.104484.
31. Dewiasty E, Agustina R, Saldi SR, Pramudita A, Hinssen F, Kumaheri M, et al. Malnutrition prevalence and nutrient intakes of Indonesian community-dwelling older adults: a systematic review of observational studies. Front Nutr 2022;9:780003. 10.3389/fnut.2022.780003. 35284453.
32. Cruz-Jentoft AJ. Sarcopenia: preventable and reversible. In: Michel JP, editor. Prevention of chronic diseases and age-related disability. Cham, Germany: Springer; 2018. p. 47-52. 10.1007/978-3-319-96529-1_5.
33. Mazya AL, Garvin P, Ekdahl AW. Outpatient comprehensive geriatric assessment: effects on frailty and mortality in old people with multimorbidity and high health care utilization. Aging Clin Exp Res 2019;31:519–25. 10.1007/s40520-018-1004-z.
34. Ligthart-Melis GC, Luiking YC, Kakourou A, Cederholm T, Maier AB, de van der Schueren MA. Frailty, sarcopenia, and malnutrition frequently (co-)occur in hospitalized older adults: a systematic review and meta-analysis. J Am Med Dir Assoc 2020;21:1216–28. 10.1016/j.jamda.2020.03.006. 32327302.
35. Celik HI, Koc F, Siyasal K, Ay B, Ilter NB, Celik OM. Exploring the complex associations among risks of malnutrition, sarcopenia, and frailty in community-dwelling older adults. Eur Rev Aging Phys Act 2024;21:18. 10.1186/s11556-024-00354-7. 38982337.
36. Hu X, Zhang L, Wang H, Hao Q, Dong B, Yang M. Malnutrition-sarcopenia syndrome predicts mortality in hospitalized older patients. Sci Rep 2017;7:3171. 10.1038/s41598-017-03388-3. 28600505.
37. Xu J, Wan CS, Ktoris K, Reijnierse EM, Maier AB. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology 2022;68:361–76. 10.1159/000517099. 34315158.
38. Palmer K, Vetrano DL, Padua L, Romano V, Rivoiro C, Scelfo B, et al. Frailty syndromes in persons with cerebrovascular disease: a systematic review and meta-analysis. Front Neurol 2019;10:1255. 10.3389/fneur.2019.01255. 31849819.
39. Evans NR, Todd OM, Minhas JS, Fearon P, Harston GW, Mant J, et al. Frailty and cerebrovascular disease: concepts and clinical implications for stroke medicine. Int J Stroke 2022;17:251–9. 10.1177/17474930211034331. 34282986.
40. Buck J, Fromings Hill J, Martin A, Springate C, Ghosh B, Ashton R, et al. Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review. Age Ageing 2021;50:1108–17. 10.1093/ageing/afab024. 33693496.
41. Nip WF, Perry L, McLaren S, Mackenzie A. Dietary intake, nutritional status and rehabilitation outcomes of stroke patients in hospital. J Hum Nutr Diet 2011;24:460–9. 10.1111/j.1365-277x.2011.01173.x. 21605199.
42. Mas MF, Gonzalez J, Frontera WR. Stroke and sarcopenia. Curr Phys Med Rehabil Rep 2020;8:452–60. 10.1007/s40141-020-00284-2. 33777503.
43. Borges MK, Canevelli M, Cesari M, Aprahamian I. Frailty as a predictor of cognitive disorders: a systematic review and meta-analysis. Front Med (Lausanne) 2019;6:26. 10.3389/fmed.2019.00026. 30838210.
44. Licastro F, Pedrini S, Caputo L, Annoni G, Davis LJ, Ferri C, et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J Neuroimmunol 2000;103:97–102. 10.1016/s0165-5728(99)00226-x. 10674995.
45. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 2012;15:12–22. 10.1097/mco.0b013e32834dd297. 22108098.
46. Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R, et al. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev 2009;8:285–305. 10.1016/j.arr.2009.04.002. 19376275.
47. Assis AP, de Oliveira BT, Gomes AL, Soares AD, Guimaraes NS, Gomes JM. The association between nutritional status, advanced activities of daily living, and cognitive function among Brazilian older adults living in care homes. Geriatr Nurs 2020;41:899–904. 10.1016/j.gerinurse.2020.06.014. 32653259.
48. Steffl M, Bohannon RW, Sontakova L, Tufano JJ, Shiells K, Holmerova I. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging 2017;12:835–45. 10.2147/cia.s132940. 28553092.
49. Morley JE. Rapid geriatric assessment: secondary prevention to stop age-associated disability. Clin Geriatr Med 2017;33:431–40. 10.1016/j.cger.2017.03.006. 28689573.
50. Tan LF, Chan YH, Tay A, Jayasundram J, Low NA, Merchant RA. Practicality and reliability of self vs administered rapid geriatric assessment mobile app. J Nutr Health Aging 2021;25:1064–9. 10.1007/s12603-021-1672-9. 34725662.

Article information Continued

Fig. 1.

Frailty, SARC-F-based sarcopenia, and malnutrition diagnoses among community-dwelling older outpatients in Indonesia (n=580). SARC-F contains five items: strength, assistance in walking, rising from a chair, climbing stairs, and falls.

Fig. 2.

The postulated relationship between the overlap of frailty, possible sarcopenia and malnutrition, and TIA and cerebrovascular accident, cognitive impairment, and dependent functional capacity. TIA, transient ischemic attack.

Table 1.

Characteristics of participants (n=580)

All participants (n=580) Overlap of 3 syndromes (n=19) Frailty (n=79) Possible sarcopenia (n=264) Malnutrition (n=31)
Sex
 Male 266 (45.9) 4 (21.1) 30 (38.0) 123 (46.6) 10 (32.3)
 Female 314 (54.1) 15 (78.9) 49 (62.0) 141 (53.4) 21 (67.7)
Age group (y)
 60–69 300 (51.7) 11 (57.9) 38 (48.1) 119 (45.1) 18 (58.1)
 ≥70 280 (48.3) 8 (42.1) 41 (51.9) 145 (54.9) 13 (41.9)
Educational attainment
 High educational attainment 396 (68.3) 9 (47.4) 50 (63.3) 184 (69.7) 17 (54.8)
 Low educational attainment 184 (31.7) 10 (52.6) 29 (36.7) 80 (30.3) 14 (45.2)
Ethnic group
 Sundanese 43 (7.4) 2 (10.5) 9 (11.4) 23 (8.7) 5 (16.1)
 Batak 41 (7.1) 1 (5.3) 7 (8.9) 12 (4.5) 1 (3.2)
 Betawi 16 (2.8) 1 (5.3) 3 (3.8) 5 (1.9) 2 (6.5)
 Javanese 158 (27.2) 5 (26.3) 20 (25.3) 77 (29.2) 7 (22.6)
 Malay 82 (14.1) 1 (5.3) 13 (16.5) 51 (19.3) 2 (6.5)
 Minang 110 (19.0) 2 (10.5) 13 (16.5) 63 (23.9) 4 (12.9)
 Chinese 106 (18.3) 7 (36.8) 12 (15.2) 23 (8.7) 10 (32.3)
 Others 24 (4.1) 0 (0) 2 (2.5) 10 (3.8) 0 (0)
Smoking history
 Never-smoker 391 (67.4) 16 (84.2) 60 (75.9) 170 (64.4) 24 (77.4)
 Former or current smoker 189 (32.6) 3 (15.8) 19 (24.1) 94 (35.6) 7 (22.6)
Falls
 No 485 (83.6) 11 (57.9) 51 (64.6) 204 (77.3) 20 (64.5)
 Yes 95 (16.4) 8 (42.1) 28 (35.4) 60 (22.7) 11 (35.5)
Recurrent falls
 No 567 (97.8) 17 (89.5) 77 (97.5) 259 (98.1) 29 (93.5)
 Yes 13 (2.2) 2 (10.5) 2 (2.5) 5 (1.9) 2 (6.5)
Diabetes mellitus
 No 357 (61.6) 8 (42.1) 50 (63.3) 182 (68.9) 16 (51.6)
 Yes 223 (38.4) 11 (57.9) 29 (36.7) 82 (31.1) 15 (48.4)
Chronic kidney disease
 No 527 (90.9) 17 (89.5) 70 (88.6) 245 (92.8) 27 (87.1)
 Yes 53 (9.1) 2 (10.5) 9 (11.4) 19 (7.2) 4 (12.9)
Cardiovascular disease
 No 361 (62.2) 10 (52.6) 38 (48.1) 156 (59.1) 14 (45.2)
 Yes 219 (37.8) 9 (47.4) 41 (51.9) 108 (40.9) 17 (54.8)
TIA and cerebrovascular accident
 No 541 (93.3) 14 (73.7) 69 (87.3) 243 (92.0) 25 (80.6)
 Yes 39 (6.7) 5 (26.3) 10 (12.7) 21 (8.0) 6 (19.4)
Dementia
 No 564 (97.2) 17 (89.5) 72 (91.1) 253 (95.8) 29 (93.5)
 Yes 16 (2.8) 2 (10.5) 7 (8.9) 11 (4.2) 2 (6.5)
Hypertension
 No 186 (32.1) 8 (42.1) 21 (26.6) 87 (33.0) 12 (38.7)
 Yes 394 (67.9) 11 (57.9) 58 (73.4) 177 (67.0) 19 (61.3)
Osteoarthritis
 No 488 (84.1) 15 (78.9) 67 (84.8) 225 (85.2) 23 (74.2)
 Yes 92 (15.9) 4 (21.1) 12 (15.2) 39 (14.8) 8 (25.8)
Dyslipidaemia
 No 413 (71.2) 13 (68.4) 66 (83.5) 223 (84.5) 22 (71.0)
 Yes 167 (28.8) 6 (31.6) 13 (16.5) 41 (15.5) 9 (29.0)
Multimorbidity
 No 112 (19.3) 4 (21.1) 16 (20.3) 62 (23.5) 6 (19.4)
 Yes 468 (80.7) 15 (78.9) 63 (79.7) 202 (76.5) 25 (80.6)
Polypharmacy
 No 411 (70.9) 16 (84.2) 51 (64.6) 176 (66.7) 27 (87.1)
 Yes 169 (29.1) 3 (15.8) 28 (35.4) 88 (33.3) 4 (12.9)
Cognitive impairment
 No 437 (75.3) 8 (42.1) 55 (69.6) 222 (84.1) 15 (48.4)
 Yes 143 (24.7) 11 (57.9) 24 (30.4) 42 (15.9) 16 (51.6)
Functional status
 Independent 427 (73.6) 4 (21.1) 26 (32.9) 154 (58.3) 14 (45.2)
 Dependent 153 (26.4) 15 (78.9) 53 (67.1) 110 (41.7) 17 (54.8)
Depression
 No 526 (90.7) 14 (73.7) 54 (68.4) 232 (87.9) 23 (74.2)
 Yes 54 (9.3) 5 (26.3) 25 (31.6) 32 (12.1) 8 (25.8)

Values are presented as number (%).

Table 2.

The odds ratio for the association between each factor and the overlap of frailty, possible sarcopenia, and malnutrition

Crude Adjusted
OR (95% CI) p-value OR (95% CI) p-value
Sex
 Male Ref Ref
 Female 3.29 (1.08–10.02) 0.027 3.51 (0.59–20.83) 0.167
Age group (y)
 60–69 Ref -
 ≥70 0.77 (0.31–1.95) 0.584 N/A
Educational attainment
 High educational attainment Ref Ref
 Low educational attainment 2.47 (0.99–6.19) 0.046 0.99 (0.32–3.08) 0.984
Smoking history
 Never-smoker Ref Ref
 Former or current smoker 0.38 (0.11–1.31) 0.112 0.97 (0.14–6.55) 0.970
Falls
 No Ref Ref
 Yes 3.96 (1.55–10.13) 0.002 2.00 (0.62–6.43) 0.246
Recurrent falls
 No Ref Ref
 Yes 5.88 (1.21–28.62) 0.013 1.43 (0.17–12.24) 0.745
Diabetes mellitus
 No Ref Ref
 Yes 2.26 (0.90–5.72) 0.076 2.03 (0.68–6.08) 0.208
Chronic kidney disease
 No Ref -
 Yes 1.18 (0.26–5.24) 0.831 N/A
Cardiovascular disease
 No Ref -
 Yes 1.50 (0.60–3.76) 0.380 N/A
TIA and cerebrovascular accident
 No Ref Ref
 Yes 5.54 (1.88–16.28) 0.001 5.53 (1.48–20.61) 0.011
Dementia
 No Ref Ref
 Yes 4.60 (0.97–21.84) 0.036 0.43 (0.05–3.40) 0.422
Hypertension
 No Ref -
 Yes 0.64 (0.25–1.62) 0.341 N/A
Osteoarthritis
 No Ref -
 Yes 1.43 (0.47–4.42) 0.529 N/A
Dyslipidaemia
 No Ref -
 Yes 1.15 (0.43–3.07) 0.785 N/A
Multimorbidity
 No Ref -
 Yes 0.89 (0.29–2.75) 0.845 N/A
Polypharmacy
 No Ref Ref
 Yes 0.45 (0.13–1.55) 0.193 0.38 (0.09–1.65) 0.197
Cognitive impairment
 No Ref Ref
 Yes 4.47 (1.76–11.34) 0.001 3.70 (1.21–11.31) 0.022
Functional status
 Independent Ref Ref
 Dependent 11.50 (3.75–35.21) <0.001 11.62 (3.38–39.99) <0.001
Depression
 No Ref Ref
 Yes 3.73 (1.29–10.80) 0.009 2.78 (0.78–9.94) 0.115

TIA, transient ischemic attack; OR, odds ratio; CI, confidence interval; N/A, not applicable.